Study of Enzyme Supplements to Treat Celiac Disease

NCT00962182 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Celiac Disease
Dermatitis Herpetiformis

Interventions

DRUG: STAN1
DRUG: Placebo enzyme
DRUG: STAN1+gluten

Sponsor

Heim Pal Children's Hospital

Collaborators

[object Object]